Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
Adenosine levels in the exhaled breath condensate: a potential surrogate marker of airway inflammation Source: Eur Respir J 2003; 22: 392 Year: 2003
Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Exhaled breath condensate: is this yet of clinical value? Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice Year: 2005
Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes. Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004
Relationship between hydrogen peroxide levels in exhaled breath condensate and long term changes in small airway function of patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011
Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases Year: 2010
Targeted eicosanoid lipidomics of induced sputum as compared to exhaled breath condensate in asthmatics Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010
Exhaled breath condensate pH standardised for CO2 partial pressure Source: Eur Respir J 2007; 29: 496-501 Year: 2007
Inflammatory markers in exhaled breath condensate of two COPD phenotypes Source: Eur Respir J 2005; 26: Suppl. 49, 260s Year: 2005
Inflammatory mediators in exhaled breath condensate, induced sputum and saliva Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004
Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: 1011-1017 Year: 2004